Clinical trial
Impact of Insulin Detemir Versus Insulin Glargine on Glycaemic Control and Metabolism During Exercise in Type 1 Diabetes
NCT01440439 is registered in ClinicalTrials.gov with Buckinghamshire Healthcare NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Insulin Detemir Versus Insulin Glargine on Glycaemic Control and Metabolism During Exercise in Type 1 Diabetes
- Lead sponsor
- Buckinghamshire Healthcare NHS Trust
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- November 30, 2011
- Completion date
- June 30, 2012
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.